CSL Behring Publishes Design for First-Ever Outcomes Study of ApoA-I to Reduce Risk of Cardiovascular Events in Heart Attack Patients ...Middle East

KING OF PRUSSIA, Pa., Nov. 5, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the study design manuscript for its landmark AEGIS-II (ApoA-I Event reducinG in Ischemic Syndromes II) has been published in the American Heart Journal. The Phase 3 trial,...

Read More Details
Finally We wish PressBee provided you with enough information of ( CSL Behring Publishes Design for First-Ever Outcomes Study of ApoA-I to Reduce Risk of Cardiovascular Events in Heart Attack Patients )

Also on site :

• I Use This Solar-Powered Security Camera to Keep My Home Safe, and It's $24 Off for Prime Day
• Merck spends $10 billion for Verona, gaining access to its COPD medication
• Perris mayor tells residents to stay inside after reports of ICE activity